The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / D••••••••• B••

••• Locked

Add-on acquisitionclosedadd-onannounced Dec 20, 2020closed Dec 20, 2020Fact
What happened
Target
D••••••••• B••
Platform
C•••••• R•••• L•••••••••add-on basis: D••••••••• B•• Acquired By C•••••• R•••• L••••••••• | C•••••• R•••• L••••••••• is held by B••••••• Asset on its portfolio page; published on B••••••• Asset's own news page
Control
Control
Share acquired
unknown
Industry
healthcare / laborator, life sciences
Target location
CA, US
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
$83.0M (disclosed by a party)
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Side not stated
Evidence
“••• Locked”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 20, 2026
••• Locked | Private Equity Intelligence | DFX